Elizabeth Eisenhauer


Ontology type: schema:Person     


Person Info

NAME

Elizabeth

SURNAME

Eisenhauer

Publications in SciGraph latest 50 shown

  • 2017-12 A phase-I study of lapatinib in combination with foretinib, a c-MET, AXL and vascular endothelial growth factor receptor inhibitor, in human epidermal growth factor receptor 2 (HER-2)-positive metastatic breast cancer in BREAST CANCER RESEARCH
  • 2016-05 Canadian Cancer Trials Group IND197: a phase II study of foretinib in patients with estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2-negative recurrent or metastatic breast cancer in BREAST CANCER RESEARCH AND TREATMENT
  • 2016-03 Randomized study of sequential cisplatin-topotecan/carboplatin-paclitaxel versus carboplatin-paclitaxel: effects on quality of life in SUPPORTIVE CARE IN CANCER
  • 2015-08 A phase II study of the HDAC inhibitor SB939 in patients with castration resistant prostate cancer: NCIC clinical trials group study IND195 in INVESTIGATIONAL NEW DRUGS
  • 2012-12 A phase I study of temozolomide and everolimus (RAD001) in patients with newly diagnosed and progressive glioblastoma either receiving or not receiving enzyme-inducing anticonvulsants: an NCIC CTG study in INVESTIGATIONAL NEW DRUGS
  • 2011-03 Phase I clinical, pharmacokinetic and pharmacodynamic study of SB939, an oral histone deacetylase (HDAC) inhibitor, in patients with advanced solid tumours in BRITISH JOURNAL OF CANCER
  • 2010-01 A phase I/II trial of GW572016 (lapatinib) in recurrent glioblastoma multiforme: clinical outcomes, pharmacokinetics and molecular correlation in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 2008-06 A phase II and pharmacokinetic study of SB-715992, in patients with metastatic hepatocellular carcinoma: a study of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG IND.168) in INVESTIGATIONAL NEW DRUGS
  • 2008-06 A phase II study of ispinesib (SB-715992) in patients with metastatic or recurrent malignant melanoma: a National Cancer Institute of Canada Clinical Trials Group trial in INVESTIGATIONAL NEW DRUGS
  • 2007-10 Phase II study of Triapine® in patients with metastatic renal cell carcinoma: a trial of the National Cancer Institute of Canada Clinical Trials Group (NCIC IND.161) in INVESTIGATIONAL NEW DRUGS
  • 2007-06 A phase I study of oral LY293111 given daily in combination with irinotecan in patients with solid tumours in INVESTIGATIONAL NEW DRUGS
  • 2006-11 A phase II study of ZD6474 (Zactima™), a selective inhibitor of VEGFR and EGFR tyrosine kinase in patients with relapsed multiple myeloma—NCIC CTG IND.145 in INVESTIGATIONAL NEW DRUGS
  • 2006-09 A phase II study of perifosine (D-21226) in patients with previously untreated metastatic or locally advanced soft tissue sarcoma: A National Cancer Institute of Canada Clinical Trials Group trial in INVESTIGATIONAL NEW DRUGS
  • 2006-07 SarCNU in recurrent or metastatic colorectal cancer: A phase II study of the National Cancer Institute of Canada Clinical Trials Group in INVESTIGATIONAL NEW DRUGS
  • 2006-03 Phase II trial of DNA methyltransferase 1 inhibition with the antisense oligonucleotide MG98 in patients with metastatic renal carcinoma: A National Cancer Institute of Canada Clinical Trials Group investigational new drug study in INVESTIGATIONAL NEW DRUGS
  • 2005-12 Phase II Trial of SarCNU in Malignant Glioma: Unexpected Pulmonary Toxicity with a Novel Nitrosourea in INVESTIGATIONAL NEW DRUGS
  • 2005-12 Phase II Study of Perifosine in Previously Untreated Patients with Metastatic Melanoma in INVESTIGATIONAL NEW DRUGS
  • 2005-03 New guidelines to evaluate the response to treatment in solid tumors in BREAST CANCER
  • 2004-08 Phase II trial of flavopiridol, a cyclin dependent kinase inhibitor, in untreated metastatic malignant melanoma in INVESTIGATIONAL NEW DRUGS
  • 2004-08 A phase 1 study of OSI-211 given as an intravenous infusion days 1, 2, and 3 every three weeks in patients with solid cancers in INVESTIGATIONAL NEW DRUGS
  • 2004-04 Phase I and Pharmacokinetic Study of Fostriecin given as an Intravenous Bolus Daily for Five Consecutive Days in INVESTIGATIONAL NEW DRUGS
  • 2003-11 A phase II study of topotecan in patients with anaplastic oligodendroglioma or anaplastic mixed oligoastrocytoma in INVESTIGATIONAL NEW DRUGS
  • 2003-02 Phase I and Pharmacologic Study of the Human DNA Methyltransferase Antisense Oligodeoxynucleotide MG98 given as a 21-day Continuous Infusion Every 4 Weeks in INVESTIGATIONAL NEW DRUGS
  • 2002-11 Phase II Study of Marimastat (BB-2516) in Malignant Melanoma – A Clinical and Tumor Biopsy Study of the National Cancer Institute of Canada Clinical Trials Group in INVESTIGATIONAL NEW DRUGS
  • 2001-01 A review of dose-limiting events in phase I trials: antimetabolites show unpredictable relationships between dose and toxicity in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 1999-05 The sulfhydryl containing compounds WR-2721 and glutathione as radio- and chemoprotective agents. A review, indications for use and prospects in BRITISH JOURNAL OF CANCER
  • 1998-01 The Taxoids in DRUGS
  • 1995-12 Phase II study of docetaxel (taxotere) in patients with previously untreated extensive small cell lung cancer in INVESTIGATIONAL NEW DRUGS
  • 1995 The European—Canadian study of paclitaxel in ovarian cancer. High vs low dose; long vs short infusion in OVARIAN CANCER 3
  • 1994-12 Phase II study of elsamitrucin in non-small cell lung cancer in INVESTIGATIONAL NEW DRUGS
  • 1993-12 Phase I pharmacokinetic study of DUP-937, a new anthrapyrazole in INVESTIGATIONAL NEW DRUGS
  • 1993-06 Phase II study on DuP 937 (Teloxantrone) in colorectal carcinoma in INVESTIGATIONAL NEW DRUGS
  • 1993-02 Phase II study of tiazofurin in gliomas in adults in JOURNAL OF NEURO-ONCOLOGY
  • 1991-08 Phase II study of 2′-deoxycoformycin in patients with renal cell carcinoma in INVESTIGATIONAL NEW DRUGS
  • 1991-02 A phase II study of menogaril in low-grade non-Hodgkin's lymphoma in INVESTIGATIONAL NEW DRUGS
  • 1990-08 Activity of intravenous menogaril in patients with previously untreated metastatic breast cancer in INVESTIGATIONAL NEW DRUGS
  • 1990-02 Phase II study of trimetrexate in malignant melanoma: A National Cancer Institute of Canada Clinical Trials Group Study in INVESTIGATIONAL NEW DRUGS
  • 1989-03 Hypersensitivity reactions to deoxycoformycin in CANCER CHEMOTHERAPY AND PHARMACOLOGY
  • 1988-12 A phase II study of VP-16 and cisplatin in patients with unresectable malignant mesothelioma in INVESTIGATIONAL NEW DRUGS
  • 1988-10 VP-16 and carboplatin in previously untreated patients with extensive small cell lung cancer: a study of the National Cancer Institute of Canada Clinical Trials Group in BRITISH JOURNAL OF CANCER
  • 1988-09 Phase II study of flutamide in patients with metastatic breast cancer. A National Cancer Institute of Canada Clinical Trials Group study in INVESTIGATIONAL NEW DRUGS
  • 1988 A Pilot Study of Adriamycin, Dacarbazine and Ifosfamide in Advanced Adult Soft Tissue Sarcomas in RECENT CONCEPTS IN SARCOMA TREATMENT
  • 1987-12 Phase II study of acivicin as a 72-hr continuous infusion in patients with untreated colorectal cancer. A National Cancer Institute of Canada clinical trials group study in INVESTIGATIONAL NEW DRUGS
  • 1985-09 A phase II study of spirogermanium as second line therapy in patients with poor prognosis lymphoma in INVESTIGATIONAL NEW DRUGS
  • 1985-09 A phase II study of spirogermanium in patients with metastatic malignant melanoma in INVESTIGATIONAL NEW DRUGS
  • Affiliations

  • Queen's University (current)
  • University Hospital Schleswig-Holstein
  • National Cancer Institute
  • Eastern Cooperative Oncology Group
  • Kingston General Hospital
  • NIHR Clinical Research Network
  • Hamilton Health Sciences
  • University of Münster
  • Centre Hospitalier de l’Université de Montréal
  • Hannover Medical School
  • Vancouver General Hospital
  • Latin American and Caribbean Society of Medical Oncology
  • Royal Victoria Regional Health Centre
  • Mount Vernon Hospital
  • University of Pittsburgh
  • GlaxoSmithKline (Belgium)
  • Ludwig Maximilian University of Munich
  • Singapore Science Park
  • CancerCare Manitoba
  • University of Massachusetts Medical School
  • Rechts der Isar Hospital
  • Universitaire Ziekenhuizen Leuven
  • Ministère des Affaires sociales et de la Santé
  • Weston Park Hospital
  • Moffitt Cancer Center
  • Eli Lilly (United States)
  • University of Toronto
  • Odense University Hospital
  • UNSW Australia
  • Canadian Breast Cancer Network
  • Birmingham City Hospital
  • Universitätsklinikum Tübingen
  • University of Alberta
  • Vancouver Clinic
  • Saitama Medical University
  • Beth Israel Deaconess Medical Center
  • Chinese University of Hong Kong
  • MRC Clinical Trials Unit
  • Juravinski Cancer Centre
  • BC Cancer Agency
  • Centre Hospitalier Universitaire de Québec
  • Central University Hospital of Asturias
  • Sunnybrook Health Science Centre
  • Alberta Health Services
  • National Institute of Child Health and Human Development
  • University Hospital Magdeburg
  • Queen Elizabeth II Health Sciences Centre
  • University of Saskatchewan
  • The Christie Hospital
  • Mayo Clinic
  • Saskatchewan Cancer Agency
  • University of Washington
  • Mount Vernon Cancer Centre
  • Helios Dr. Horst Schmidt Kliniken Wiesbaden
  • Gartnavel General Hospital
  • Institut Jules Bordet
  • University of Montreal
  • University of British Columbia
  • Thunder Bay Regional Health Sciences Centre
  • Gdańsk Medical University
  • European Organisation for Research and Treatment of Cancer
  • McGill University
  • Newcastle University
  • Princess Margaret Cancer Centre
  • Peace Corps
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.410356.5", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.412468.d", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.48336.3a", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.428556.8", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.415354.2", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.470347.3", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.413615.4", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.5949.1", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.410559.c", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.10423.34", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.412541.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.489787.d", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.416249.c", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.416188.2", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.21925.3d", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.425090.a", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.5252.0", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.420208.c", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.419404.c", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.168645.8", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.15474.33", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.410569.f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.418199.c", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.417079.c", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.468198.a", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.417540.3", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.17063.33", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.7143.1", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.1005.4", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.420095.a", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.412918.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411544.1", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.17089.37", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.490552.f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.410802.f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.239395.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.10784.3a", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.415052.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.477522.1", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.248762.d", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411081.d", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411052.3", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.413104.3", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.413574.0", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.420089.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.411559.d", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.413292.f", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.25152.31", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.415720.5", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.66875.3a", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.419525.e", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.34477.33", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.477623.3", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.491861.3", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.415302.1", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.418119.4", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.14848.31", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.17091.3e", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.417014.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.11451.30", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.418936.1", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.14709.3b", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.1006.7", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.415224.4", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.466986.3", 
            "type": "Organization"
          }
        ], 
        "familyName": "Eisenhauer", 
        "givenName": "Elizabeth", 
        "id": "sg:person.0610741743.91", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0610741743.91"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T14:45", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_491.json", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.0610741743.91'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.0610741743.91'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.0610741743.91'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.0610741743.91'


     

    This table displays all metadata directly associated to this object as RDF triples.

    144 TRIPLES      10 PREDICATES      75 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.0610741743.91 schema:affiliation Na63a12f043ee46bdaa79f8e1ee49bedc
    2 https://www.grid.ac/institutes/grid.1005.4
    3 https://www.grid.ac/institutes/grid.1006.7
    4 https://www.grid.ac/institutes/grid.10423.34
    5 https://www.grid.ac/institutes/grid.10784.3a
    6 https://www.grid.ac/institutes/grid.11451.30
    7 https://www.grid.ac/institutes/grid.14709.3b
    8 https://www.grid.ac/institutes/grid.14848.31
    9 https://www.grid.ac/institutes/grid.15474.33
    10 https://www.grid.ac/institutes/grid.168645.8
    11 https://www.grid.ac/institutes/grid.17063.33
    12 https://www.grid.ac/institutes/grid.17089.37
    13 https://www.grid.ac/institutes/grid.17091.3e
    14 https://www.grid.ac/institutes/grid.21925.3d
    15 https://www.grid.ac/institutes/grid.239395.7
    16 https://www.grid.ac/institutes/grid.248762.d
    17 https://www.grid.ac/institutes/grid.25152.31
    18 https://www.grid.ac/institutes/grid.34477.33
    19 https://www.grid.ac/institutes/grid.410559.c
    20 https://www.grid.ac/institutes/grid.410569.f
    21 https://www.grid.ac/institutes/grid.410802.f
    22 https://www.grid.ac/institutes/grid.411052.3
    23 https://www.grid.ac/institutes/grid.411081.d
    24 https://www.grid.ac/institutes/grid.411544.1
    25 https://www.grid.ac/institutes/grid.411559.d
    26 https://www.grid.ac/institutes/grid.412468.d
    27 https://www.grid.ac/institutes/grid.412541.7
    28 https://www.grid.ac/institutes/grid.412918.7
    29 https://www.grid.ac/institutes/grid.413104.3
    30 https://www.grid.ac/institutes/grid.413292.f
    31 https://www.grid.ac/institutes/grid.413574.0
    32 https://www.grid.ac/institutes/grid.413615.4
    33 https://www.grid.ac/institutes/grid.415052.7
    34 https://www.grid.ac/institutes/grid.415224.4
    35 https://www.grid.ac/institutes/grid.415302.1
    36 https://www.grid.ac/institutes/grid.415354.2
    37 https://www.grid.ac/institutes/grid.415720.5
    38 https://www.grid.ac/institutes/grid.416188.2
    39 https://www.grid.ac/institutes/grid.416249.c
    40 https://www.grid.ac/institutes/grid.417014.7
    41 https://www.grid.ac/institutes/grid.417079.c
    42 https://www.grid.ac/institutes/grid.417540.3
    43 https://www.grid.ac/institutes/grid.418119.4
    44 https://www.grid.ac/institutes/grid.418199.c
    45 https://www.grid.ac/institutes/grid.418936.1
    46 https://www.grid.ac/institutes/grid.419404.c
    47 https://www.grid.ac/institutes/grid.419525.e
    48 https://www.grid.ac/institutes/grid.420089.7
    49 https://www.grid.ac/institutes/grid.420095.a
    50 https://www.grid.ac/institutes/grid.420208.c
    51 https://www.grid.ac/institutes/grid.425090.a
    52 https://www.grid.ac/institutes/grid.428556.8
    53 https://www.grid.ac/institutes/grid.466986.3
    54 https://www.grid.ac/institutes/grid.468198.a
    55 https://www.grid.ac/institutes/grid.470347.3
    56 https://www.grid.ac/institutes/grid.477522.1
    57 https://www.grid.ac/institutes/grid.477623.3
    58 https://www.grid.ac/institutes/grid.48336.3a
    59 https://www.grid.ac/institutes/grid.489787.d
    60 https://www.grid.ac/institutes/grid.490552.f
    61 https://www.grid.ac/institutes/grid.491861.3
    62 https://www.grid.ac/institutes/grid.5252.0
    63 https://www.grid.ac/institutes/grid.5949.1
    64 https://www.grid.ac/institutes/grid.66875.3a
    65 https://www.grid.ac/institutes/grid.7143.1
    66 schema:familyName Eisenhauer
    67 schema:givenName Elizabeth
    68 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0610741743.91
    69 schema:sdDatePublished 2019-03-07T14:45
    70 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    71 schema:sdPublisher Nffa12f0ccd0d4423800804f2e50e612d
    72 sgo:license sg:explorer/license/
    73 sgo:sdDataset persons
    74 rdf:type schema:Person
    75 Na63a12f043ee46bdaa79f8e1ee49bedc schema:affiliation https://www.grid.ac/institutes/grid.410356.5
    76 sgo:isCurrent true
    77 rdf:type schema:OrganizationRole
    78 Nffa12f0ccd0d4423800804f2e50e612d schema:name Springer Nature - SN SciGraph project
    79 rdf:type schema:Organization
    80 https://www.grid.ac/institutes/grid.1005.4 schema:Organization
    81 https://www.grid.ac/institutes/grid.1006.7 schema:Organization
    82 https://www.grid.ac/institutes/grid.10423.34 schema:Organization
    83 https://www.grid.ac/institutes/grid.10784.3a schema:Organization
    84 https://www.grid.ac/institutes/grid.11451.30 schema:Organization
    85 https://www.grid.ac/institutes/grid.14709.3b schema:Organization
    86 https://www.grid.ac/institutes/grid.14848.31 schema:Organization
    87 https://www.grid.ac/institutes/grid.15474.33 schema:Organization
    88 https://www.grid.ac/institutes/grid.168645.8 schema:Organization
    89 https://www.grid.ac/institutes/grid.17063.33 schema:Organization
    90 https://www.grid.ac/institutes/grid.17089.37 schema:Organization
    91 https://www.grid.ac/institutes/grid.17091.3e schema:Organization
    92 https://www.grid.ac/institutes/grid.21925.3d schema:Organization
    93 https://www.grid.ac/institutes/grid.239395.7 schema:Organization
    94 https://www.grid.ac/institutes/grid.248762.d schema:Organization
    95 https://www.grid.ac/institutes/grid.25152.31 schema:Organization
    96 https://www.grid.ac/institutes/grid.34477.33 schema:Organization
    97 https://www.grid.ac/institutes/grid.410356.5 schema:Organization
    98 https://www.grid.ac/institutes/grid.410559.c schema:Organization
    99 https://www.grid.ac/institutes/grid.410569.f schema:Organization
    100 https://www.grid.ac/institutes/grid.410802.f schema:Organization
    101 https://www.grid.ac/institutes/grid.411052.3 schema:Organization
    102 https://www.grid.ac/institutes/grid.411081.d schema:Organization
    103 https://www.grid.ac/institutes/grid.411544.1 schema:Organization
    104 https://www.grid.ac/institutes/grid.411559.d schema:Organization
    105 https://www.grid.ac/institutes/grid.412468.d schema:Organization
    106 https://www.grid.ac/institutes/grid.412541.7 schema:Organization
    107 https://www.grid.ac/institutes/grid.412918.7 schema:Organization
    108 https://www.grid.ac/institutes/grid.413104.3 schema:Organization
    109 https://www.grid.ac/institutes/grid.413292.f schema:Organization
    110 https://www.grid.ac/institutes/grid.413574.0 schema:Organization
    111 https://www.grid.ac/institutes/grid.413615.4 schema:Organization
    112 https://www.grid.ac/institutes/grid.415052.7 schema:Organization
    113 https://www.grid.ac/institutes/grid.415224.4 schema:Organization
    114 https://www.grid.ac/institutes/grid.415302.1 schema:Organization
    115 https://www.grid.ac/institutes/grid.415354.2 schema:Organization
    116 https://www.grid.ac/institutes/grid.415720.5 schema:Organization
    117 https://www.grid.ac/institutes/grid.416188.2 schema:Organization
    118 https://www.grid.ac/institutes/grid.416249.c schema:Organization
    119 https://www.grid.ac/institutes/grid.417014.7 schema:Organization
    120 https://www.grid.ac/institutes/grid.417079.c schema:Organization
    121 https://www.grid.ac/institutes/grid.417540.3 schema:Organization
    122 https://www.grid.ac/institutes/grid.418119.4 schema:Organization
    123 https://www.grid.ac/institutes/grid.418199.c schema:Organization
    124 https://www.grid.ac/institutes/grid.418936.1 schema:Organization
    125 https://www.grid.ac/institutes/grid.419404.c schema:Organization
    126 https://www.grid.ac/institutes/grid.419525.e schema:Organization
    127 https://www.grid.ac/institutes/grid.420089.7 schema:Organization
    128 https://www.grid.ac/institutes/grid.420095.a schema:Organization
    129 https://www.grid.ac/institutes/grid.420208.c schema:Organization
    130 https://www.grid.ac/institutes/grid.425090.a schema:Organization
    131 https://www.grid.ac/institutes/grid.428556.8 schema:Organization
    132 https://www.grid.ac/institutes/grid.466986.3 schema:Organization
    133 https://www.grid.ac/institutes/grid.468198.a schema:Organization
    134 https://www.grid.ac/institutes/grid.470347.3 schema:Organization
    135 https://www.grid.ac/institutes/grid.477522.1 schema:Organization
    136 https://www.grid.ac/institutes/grid.477623.3 schema:Organization
    137 https://www.grid.ac/institutes/grid.48336.3a schema:Organization
    138 https://www.grid.ac/institutes/grid.489787.d schema:Organization
    139 https://www.grid.ac/institutes/grid.490552.f schema:Organization
    140 https://www.grid.ac/institutes/grid.491861.3 schema:Organization
    141 https://www.grid.ac/institutes/grid.5252.0 schema:Organization
    142 https://www.grid.ac/institutes/grid.5949.1 schema:Organization
    143 https://www.grid.ac/institutes/grid.66875.3a schema:Organization
    144 https://www.grid.ac/institutes/grid.7143.1 schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...